The role of corticotropin releasing factor in depressive illness: A critical review

Neuroscience and Biobehavioral Reviews

Volumn 22, Issue 5, 1998, Pages 635-651

  Mitchell, Alexander J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cerebrospinal fluid; Corticotropin releasing factor hormone; CRF receptors; Depression; Glucocorticoid receptors; HPA axis

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; NEUROPEPTIDE;

AFFECTIVE NEUROSIS; AGING; ANIMAL BEHAVIOR; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; DEPRESSION; DRUG MECHANISM; FEEDBACK SYSTEM; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFE EVENT; LUMBAR PUNCTURE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; REVIEW; STRESS;

EID: 0031777538     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(97)00059-6     Document Type: Article

References (155)

1. Abramson L. Y., Seligman M. E.P., Teasdale J. Learned helplessness in humans: Critique and reformulation. J. Abnorm. Psychol. 87:1978;49-74.
2. Altshuler L. L., Conrad A., Hauser P., Li X. M., Guze B. H., Denikoff K., Tourtellotte W., Post R. Reduction in temporal lobe volume in bipolar disorder: A preliminary report of magnetic resonance imaging (letter). Arch. Gen. Psychiatry. 48:1991;482-483.
3. American Psychiatric Association Committee on Nomenclature and Statistics, Diagnostic and Statistical Manual of Mental Disorders (3rd edn, rev.). American Psychiatric Association, Washington DC, 1980.
4. Anderson S. M., Kant G. J., De Souza E. B. Effects of chronic stress on anterior pituitary and brain corticotropin-releasing factor receptors. Pharmacol. Biochem. Behav. 44:1993;755-761.
5. Antonni F. A. Vasopressinergic controls of the pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrin. 14:1993;76-122.
6. Arató, M., Banki, C. M., Nemeroff, C. B., Bissette, G., Hypothalamic-pituitary-adrenal axis and suicide. In Psychobiology of Suicidal Behaviour, Vol. 487, ed. J. J. Mann and M. Stanley. Ann. N. Y. Acad. Sci., 1986, pp. 263-270.
7. Arató M., Banki C. M., Bissette G., Nemeroff C. B. Elevated CSF CRF in suicide victims. Biol. Psychiatry. 25:1989;355-359.
8. Aubry J. M., Pozzoli G., Vale W. W. Chronic treatment with amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdala. Biol. Psychiatry. 42:1997;236S.
9. Axelson D. A., Doraiswamy P. M., McDonald W. M., Boyko O. B., Tupler L. A., Patterson L. J., Nemeroff C. B., Ellinwood E. H. Jr., Krishnan K. R.R. Hypercortisolaemia and hippocampal changes in depression. Psych. Res. 47:1993;163-173.
10. Banki C. M., Bissette G., Arató M., O'Conner L., Nemeroff C. B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am. J. Psychiatry. 144:1987;873-877.
11. Banki C. M., Karmacsi L., Bissette G., Nemeroff C. B. Cerebrospinal fluid neuropeptides in mood disorder and dementia. J. Aff. Dis. 25:1992;39-46.
12. Banki C. M., Karmacsi L., Bissette G., Nemeroff C. B. CSF corticotropin-releasing hormone and somatostatin in major depression: Response to antidepressant treatment and relapse. Euro. Neuropsychopharmacol. 2:1992;107-113.
13. Baram T. Z., Mitchell W. G., Haden E. Inhibition of pituitary-adrenal secretion by a corticotropin releasing hormone antagonist in humans. Mol. Psychiatry. 1:1996;320-324.
14. Barden N., Reul J. M.H. M., Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? TINS. 18(1):1995;6-11.
15. Beck, A. T., Depression: Clinical, Experimental, and Theoretical Aspects. Staples Press, London, 1967.
16. Behan D. P., De Souza E. N., Lowry P. J., Potter E., Sawchenko P., Vale W. W. Corticotropin releasing factor (CRF) binding protein: A novel regulator of CRF and related peptides. Front. Neuroendocrin. 16:1995;362-382.
17. Bella R., Biondi R., Raffaele R., Pennisi G. Effect of acetyl-l-carnitine on geriatric patients suffering from dysthymic disorders. Int. J. Clin. Pharmacol. Res. X(6):1990;355-360.
18. Berrettini W. H., Nurnberger J. I., Zerbe R. L., Gold P. W., Chrousos G. P., Tomai T. CSF neuropeptides in euthymic bipolar patients and controls. Br. J. Psychiatry. 150:1987;208-212.
19. Birmaher B., Dahl R. E., Perel J., Williamson D. E., Nelson B., Stull S., Kaufman J., Waterman G. S., Rao U., Hguyen N., Puig-Antich J., Ryan N. D. Corticotropin-releasing hormone challenge in prepubertal major depression. Biol. Psychiatry. 39:1996;267-277.
20. Breier A., Kelsoe J. R., Kirwin P. D., Beller K. A., Wolkowitz O. M., Pickar D. Early parental loss and development of adult psychopathology. Arch. Gen. Psychiatry. 45:1988;987-993.
21. Britton K. T., Lee G., Vale W., Rivier J., Koob G. F. Corticotropin-releasing factor (CRF) receptor antagonist blocks activating and "anxiogenic" action of CRF in the rat. Brain Res. 369:1986;303-306.
22. Buwalda B., De Boer S. F., Van Kalkeren A. A., Koolhaas J. M. Physiological and behavioural effects of chronic inracerebroventicular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrin. 22(5):1997;297-309.
23. Chappell P. B., Smith M. A., Kilts C. D., Bissette G., Ritchie J., Erson C., Nemeroff C. B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 6:1986;2908-2914.
24. Charlton, B. G., Leake, A. and Ferrier, I. N., Corticotropin-releasing factor in plasma of depressed patients and controls. Lancet, 1986, 161-162.
25. Charlton B. G., Cheetham S. C., Horton R. W., Katona C. L.E., Cromptom M. R., Ferrier I. N. Corticotropin-releasing factor immunoreactivity in post-mortem brain from depressed suicides. J. Psychopharm. 2(1):1988;13-18.
26. Childs G. V., Morell J. L., Niendorf A., Aguilera G. Cytochemical studies of corticotropin-releasing factor (CRF) receptors in anterior lobe corticotrophs: Binding, glucocorticoid regulation and endocytosis of [biotinyl-ser1] CRF. Endocrinology. 119:1986;2129-2141.
27. Cizza G., Gold P. W., Chrousos G. P. High-dose transdermal estrogen, corticotropin-releasing hormone, and postnatal depression. J. Clin. Endocrin. Met. 82(2):1997;704.
28. Coplan J. D., Andrews M. W., Rosenblum L. A., Owens M. J., Friedman S., Gorman J. M., Nemeroff C. B. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: Implications for the pathophysiology of mood and anxiety disorders. Proc. Natl. Acad. Sci. USA. 93:1996;1619-1623.
29. Curtis A. L., Valentino R. J. Corticotropin-releasing factor neurotransmission in locus coeruleus: A possible site of antidepressant action. Brain Res. Bull. 35(5/6):1994;581-587.
30. De Bellis M. D., Gold P. W., Geracioti T. D. Jr., Listwak S. J.M. S., Kling M. A. Association of fluoxetine treatment with reduction in CSF concentration of corticotropin releasing hormone and argenine vasopressin in patients with major depression. Am. J. Psychiatry. 15:1993;656-657.
31. De Bellis M. D., Chrousos G. P., Dorn L. D., Burke L., Helmers K., Kling M. A., Trickett P. K., Putnam F. W. Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J. Clin. Endocrin. Met. 78(2):1994;249-255.
32. DeJong J. A., Roy A. R. Relationship of cognitive factors to CSF corticotropin releasing hormone in depression. Am. J. Psychiatry. 147:1990;350-352.
33. De Kloet E. R. Commentary steroids, stability and stress. Front. Neuroendocrin. 16:1995;416-425.
34. De Souza E. B. Corticotropin-releasing factor receptors in the rat central nervous system: Characterization and regional distribution. J. Neurosci. 7:1987;88-100.
35. De Souza E. B. Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology. 20(8):1995;789-819.
36. De Souza, E. B. and Grigoriadis, D. E., Corticotropin-releasing factor physiology, pharmacology, and role in central nervous system and immune disorders. In Psychopharamcology: The Fourth Generation of Progress, ed. F.E Bloom and D. J. Kupfer. Raven Press, New York, 1995, Ch.45, pp. 505-517.
37. Dinan T. G. Glucocorticoids and the genesis of depressive illness: A psychobiological model. Br. J. Psychiatry. 164:1994;365-371.
38. Dunn A. J., Berridge C. W. Physiological and behavioural responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
39. Ehlers C. E., Reed T. K., Henriksen S. J. Effects of corticotropin-releasing factor and growth hormone releasing factor on sleep and activity in rats. Neuroendocrinology. 42:1986;467-474.
40. Fehm H. L., Born J. Effects of corticotropin releasing hormone on human brain function: An analysis based on auditory evoked potentials. Hormone Metabolic Res. 16(Suppl.):1987;75-79.
41. France R. D., Urban B., Krishnan K. R. R., Bissette G., Banki C. M., Nemeroff C., Speilman F. J. CSF corticotropin-releasing factor-like immunoreactivity in chronic pain patients with and without major depression. Biol. Psychiatry. 23:1988;86-88.
42. Frye M. A., Mathe A. A., Gary K. A., George M. S., Corà-Locatelli G.et al. CSF neuropeptide dysregulation in patients with affective disorder (abstract). Biol. Psychiatry. 39:1996;596.
43. Fuchs E., Flügge G. Modulation of binding sites for corticotropin-releasing hormone by chronic psychosocial stress. Psychoneuroendocrinology. 20(1):1995;33-51.
44. Furutani Y., Morimoto Y., Shibahara S., Noda M., Takahashi H., Hiros T., Asai M., Inayama S., Hayashida H., Miyata T., Numa S. Cloning and sequence analysis of cDNA for ovine corticotropin-releasing factor precursor. Nature. 301:1983;537-540.
45. Geracioti T. D., Orth D. N., Ekhator N. N., Blumenkopf B., Loosen P. T. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J. Clin. Endocrin. Met. 74(6):1992;1325-1330.
46. Geracioti T. D., Loosen P. Y., Orth D. N. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biol. Psychiatry. 42:1997;166-174.
47. Gjerris A., Hummer M., Vendsorg P., Christienson P., Rafaelson O. J. Cerebrospinal fluid vasopressin-changes in depression. Br. J. Psychiatry. 147:1985;696-701.
48. Gold P. W., Chrousos G., Kellner C., Post R., Roy A., Augerinos P., Schulte H., Oldfield E., Loriaux D. L. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am. J. Psychiatry. 141(5):1984;619-627.
49. Gold P. W., Loriaux D. L., Roy A., Kling M. A., Calabrese J. R., Kellner C. H., Nieman L. K., Post R. M., Pickar D., Gallucci W., Avgerinos P., Paul S., Oldfield E. H., Cutler G. B., Chrousos G. P. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N. Eng. J. Med. 314(21):1986;1329-1335.
50. Grigoriadis, D. E., Lovenberg, T. W., Chalmers, D. T., Liaw, C. and De Souza, E. B., Characterization of corticotropin-releasing factor receptor subtypes. In Neuropeptides: Basic and Clinical Advances, Vol. 780, ed. J. M. Crawley and S. McLean. Ann. N. Y. Acad. Sci., 1996, pp. 60-80.
51. Hamilton M. A. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
52. Harbuz M. S., Lightman S. L. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J. Endocrin. 122:1989;705-711.
53. Hartline K. M., Owens M. J., Nemeroff C. B. Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans. Ann. N. Y. Acad. Sci. 780:1996;96-105.
54. Hathaway S. R., McKinley J. C. A multiphasic personality schedule (Minnesota): I Construction of the schedule. J. Psychol. 10:1940;249-254.
55. Hauger R. L., Millan M. A., Lorang M., Harwood J. P., Aguilera G. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Endocrinology. 123:1988;396-405.
56. Hayden-Hixson, D. M. and Nemeroff, C. B., Role(s) of neuropeptides in responding and adaption to stress: A focus on corticotropin-releasing factor and opioid peptides. In Stress From Synapse to Syndrome, ed. S. C. Stanford and P. Salmon. Academic Press, London, 1993, Ch. 13, pp. 355-391.
57. Heinrichs S. C., Min H., Tamraz S., Carmouché M., Boehme S. A., Vale W. W. Anti-sexual and anxiogenic behavioural consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinology. 22(4):1997;215-224.
58. Heit S., Owens M. J., Plotsky P., Nemeroff C. B. Corticotropin-releasing factor, stress, and depression. Neuroscientist. 3:1997;186-194.
59. Hermus A. R.M. M., Pieters G. F.M., Bartelink A. K.M., Smals A. G.H., Kloppenborg P. W.C. Serious reactions to CRF. Lancet. I:1983;776.
60. Heroux J. A., Grigoriadis D. E., De Souza E. B. Age-related decreases in corticotropin-releasing factor (CRF) receptors in the rat brain and anterior pituitary gland. Brain Res. 542:1991;155-158.
61. Heuser I., Yassouridid A., Holsboer F. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J. Psych. Res. 28(4):1994;341-356.
62. Holsboer F., Bardeleben U. V., Gerken A., Stalla G. K., Müller O. A. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor (h-CRF) in depression (letter). N. Eng. J. Med. 311(17):1984;1127.
63. Holsboer, F., Grasser, A., Freiss, E. and Wiedemann, K., Steroid effects on central neurons and implications for psychiatric and neurological disorders In Brain Corticosteroid Receptors Studies on the Mechanism, Vol. 746, ed. E. R. De Kloet, E. C. Azmitia and P. W. Landfield. Ann. N. Y. Acad. Sci., 1994, pp. 345-361.
64. Holsboer F., Lauer C. J., Schreiber W., Krieg J.-C. Altered hypothalamic-pituitary adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology. 62:1995;340-347.
65. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Rev. 17(2):1996;187-205.
66. Hong S.-K., Gold P. W., Herkenham M. Hypothalamic paraventricular lesions decrease corticotropin-releasing hormone in the CSF and elevate TRH mRNA in the locus coeruleus (Abstract 31211). Soc. Neurosci. Abstr. 19:1993;762.
67. Imaki T., Shibasaki T., Demura H. Regulation of gene expression in the central nervous system by stress: Molecular pathways of stress responses. Endoc. J. 42(2):1995;121-130.
68. Kalin, N., Animal models of depression and anxiety: Utility in new drug development. In Abstracts of the XXVIIth ISPNE Congress, Cascais, Portugal, 1996.
69. Kaye W. H., Gwirtsman H. E., George D. T.et al. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: Relation to state of nutrition, adrenal function, and intensity of depression. J. Clin. Endocrinol. Metab. 64:1987;203-208.
70. Kaye W. H. Neuropeptide abnormalities in anorexia nervosa. Psych. Res. 62:1996;65-74.
71. Kitayama I., Janson R. M., Cintra A., Fuxe K., Agnati L. F., Ogren S. O., Harfstrand A., Eneroth P., Gustafsson J. A. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the brain - evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptimine neuronal groups of the rostral ventromedial medulla. J. Neur. Transm. 73(3):1988;191-203.
72. Kling M. A., Roy A., Doran A. R., Calabrese J. R., Rubinow D. R., Whitfield H. J. Jr., May C., Post R. M., Chrousos G. P., Gold P. W. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: Potential clinical implications. J. Clin. Endocrin. Met. 72:1991;260-271.
73. Kling M. A., De Bellis M. D., O'Rourke D. K., Listwak S. J., Geracioti T. D., McCutcheon I. E., Kalogeras K. T., Oldfield E. H., Gold P. W. Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers. J. Clin. Endocrin. Met. 79(1):1994;233-239.
74. Koob G. F., Heinrichs S. C., Menzaghi F., Pich E. M., Britton K. T. Corticotropin-releasing factor, stress and behavior. Sem. Neurosciences. 6:1996;221-229.
75. Krishnan K. R.R., Doraiswamy P. M., Lurie S. N., Figiel G. S., Husain M. M., Boyko O. B., Ellinwood E. H., Nemeroff C. B. Pituitary size in depression. J. Clin. Endocrin. Met. 72(2):1991;256-259.
76. Krishnan, K. R.R., Doraiswamy, P. M., Venkataraman, S., Reed, D. A. and Richie, J. C., Current concepts in hypothalamo-pituitary-adrenal axis regulation. In Stress, Neuropeptides, and Systemic Disease, ed. J. A. McCubbin, P. G. Kaufmann and C. B. Nemeroff. Academic Press, New York, 1991, Ch. 2, pp. 19-36.
77. Kurlan R., Caine E., Rubin A., Nemeroff C. B., Bissette G., Zaczek R., Coyle J., Spielman F. J., Irvine C., Shoulson I. Cerebrospinal fluid correlates of depression in Huntington's disease. Arch. Neurol. 45(8):1988;881-883.
78. Ladd C. O., Owens M. J., Nemeroff C. B. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology. 137(4):1996;1212-1218.
79. Laux G., Lesch K.-P., Schwab M. Psychotropic effects of corticotropin-releasing hormone stimulation in depressed patients. Neuropsychobiology. 19:1988;40-44.
80. Leake A., Perry E. K., Perry R. H., Fairbairn A. F., Ferrier I. N. Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression. Biol. Psychiatry. 28:1990;603-608.
81. Levine, S., The ontogeny of the hypothalamic pituitary adrenal axis the influence of maternal factors. In Brain Corticosteroid Receptors Studies on the Mechanism, Function, and Neurotoxicity of Corticosteroid Action, Vol. 746, ed. E. R. De Kloet, E. C. Azmitia and P. W. Landfield. Ann. N. Y. Acad. Sci., 1994, pp. 275-293.
82. Licinio J., Gold P. W., Role of corticotropin releasing hormone 41 in depressive illness. Baillier's Clinical Endocrinology and Metabolism, 1991, 5(1), 51-57.
83. Lightman S. L. How does the hypothalamus respond to stress? Sem. Neurosci. 6:1994;215-219.
84. Linkowski P., Mendlewicz J., Leclercq R., Brasseur M., Hubain P., Goldstein J., Copinschi G., Van Cauter E. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J. Clin. Endocrin. Met. 61:1985;429-438.
85. Lisansky J., Peake G. T., Strassman R. J., Qualls C., Meikle A. W., Risch S. C., Fava G. A., Zownir-Brazis M., Hochla P., Britton D. Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pretreated with metyrapone. Arch. Gen. Psychiatry. 46:1989;641-649.
86. López J. F., Palkovits M., Arató M., Mansour A., Akil H., Watson S. J. Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology. 56:1992;491-501.
87. Maes M., Meltzer H., Cosyns P., Calabrese J., D'Hondt P., Blockx P. Adrenocorticotropic hormone, β-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone. Prog. Neuropsychopharm. Biol. Psychiatry. 18:1994;1273-1292.
88. McEwen B. S. Re-examination of the glucocorticoid hypothesis of stress and aging. Prog. Brain Res. 93:1992;365-383.
89. Meaney M. J., Aitken D. H., Sharma S., Viau V., Sarrieau A. Postnatal handling increases hippocampal glucocorticoid receptors and enhances adrenocortical negative-feedback efficacy in the rat. Neuroendocrinology. 50:1989;597-604.
90. Meaney M. J., Bhatnagar S., Diorio J., Larocque S., Francis D., O'Donnell D., Shanks N., Sharma S., Smythe J., Viau V. Molecular basis for the development of individual differences in the hypothalamic-pituitary-adrenal stress response. Cell. Molec. Biol. 13(4):1993;321-347.
91. Mitchell A. J. The contribution of hypercortisolaemia to the cognitive decline of geriatric depression. Int. J. Ger. Psychiatry. 10:1995;401-409.
92. Molchan S. E., Hill J. L., Martinez R. A., Lawlor B. A., Mellow A. M., Rubinow D. R., Bissette G., Nemeroff C. B., Sunderland T. CSF somatostatin in Alzheimer's disease and major depression: Relationship to hypothalamic-pituitary-adrenal axis and clinical measures. Psychoneuroendocrinology. 18(7):1993;509-519.
93. 2 - receptors is anxiolytic in rats. Biol. Psychiatry. 39:1996;589.
94. Morphy M. A., Fava G. A., Pedersen R. C., Zielezny M., Sonino N., Brownie A. C. Effects of metyrapone and dexamethasone upon pro-gamma-MSH plasma levels in depressed patients and healthy controls. J. Aff. Dis. 19:1990;183-189.
95. Murphy B. E.P. Treatment of major depression with steroid suppressive drugs. J. Steroid Biochem. Molec. Biol. 34(2):1991;239-244.
96. Nappi R. E., Rivest S. Ovulatory cycle influences the stimulatory effect of stress on the expression of corticotropin-releasing factor receptor messenger ribonucleic acid in the paraventricular nucleus of the female rat hypothalamus. Endocrinology. 136:1995;4073-4083.
97. Nemeroff C. B., Widerlöv E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C. D., Loosen P. T., Vale W. Elevated concentrations of corticotropin releasing factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
98. Nemeroff C. B., Owens M. J., Bissette G., Andorn A. C., Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry. 45:1988;577-579.
99. Nemeroff C. B., Bissette G., Akil H., Fink M. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy: Corticotropin-releasing factor, β-endorphin, and somatostatin. Br. J. Psychiatry. 158:1991;59-63.
100. O'Brien J. T., Ames D., Schweitzer I., Colman P., Desmond P., Tress B. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease. Br. J. Psychiatry. 168:1996;679-687.
101. Orth D. N. Corticotropin-releasing hormone in humans. Endocrine Rev. 13(2):1992;164-191.
102. Overall J. E., Gorham D. E. The brief psychiatric rating scale. Psychol. Rep. 10:1961;799-812.
103. Owens, M. J., Nemeroff, C. B., The neurobiology of corticotropin-releasing factor: Implications for affective disorders. In The Hypothalamic-Pituitary-Adrenal Axis: Physiology, Pathophysiology, and Psychiatric Implications, ed. A. F. Schatzberg and C. B. Nemeroff. Raven Press, New York, 1988, pp. 1-35.
104. Owens M. J., Nemeroff C. B. Physiology and pharmacology of corticotropin releasing factor. Pharmacol. Rev. 43(4):1991;425-473.
105. Pariante C. M., Nemeroff C. B., Miller A. H. Glucocorticoid receptors in depression. Isr. J. Med. Sci. 31:1995;705-712.
106. Patacchioli F. R., Amenta F., Ramacci M. T., Taglialatela G., Maccari S., Anglucci L. Acetyl-L-carnitine reduces the age dependant loss of glucocorticoid receptors in the rat hippocampus: An autoradiographic study. J. Neurosci. Res. 23:1989;462-466.
107. Peeters, B. W. M. M., Van Der Heijden, R., Gubbels, D. G., Vanderheyden, P. M. L., Effects of chronic antidepressant treatment on the hypothalamic-pituitary-adrenal axis of Wistar rats. In Brain Corticosteroid Receptors Studies on the Mechanism, Function, and Neurotoxicity of Corticosteroid Action, Vol. 746, ed. E. R. De Kloet, E. C. Azmitia and P. W. Landfield. Ann. N. Y. Acad. Sci., 1994, pp. 449-452.
108. Pihoker C., Owens M. J., Kuhn C. M., Schanberg S. M., Nemeroff C. B. Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenocortical axis: A putative role for corticotropin releasing factor. Psychoneuroendocrinology. 18(7):1993;485-493.
109. Pitts A. F., Samuelson S. D., Meller W. H., Bissette G., Nemeroff C. B., Kathol R. G. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients. Biol. Psychiatry. 38:1995;330-335.
110. Plotsky P. M., Meaney M. J. Early postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Mol. Brain Res. 18(3):1993;195-200.
111. Pomara N., Singh R. R., Deptula D., LeWitt P. A., Bissette G., Stanley M., Nemeroff C. B. Cerebrospinal fluid corticotropin-releasing factor in Alzheimer's disease: Relationship to severity of dementia and monoamine metabolites. Biol. Psychiatry. 26(5):1989;500-504.
112. Raadsheer F. C., Hoogendijk W. J. G., Stam F. C., Tilders F. J. H., Swaab D. F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 60:1994;436-444.
113. Raadsheer F. C., Van Heerikhuize J. J., Lucassen P. J., Hoogendijk W. J. G., Tilders F. J. H., Swaab D. F. Corticotropin-releasing hormone mRNA in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry. 152:1995;1372-1376.
114. Reul J. M. H. M., Labeur M. S., Grigoriadis D. E., De Souza E. B., Holsboer F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology. 60:1994;509-519.
115. Ribeiro S. C. M., Tandon R., Grunhaus L., Greden J. F. The DST as a predictor of outcome in depression: A meta-analysis. Am. J. Psychiatry. 150:1993;1618-1629.
116. Risch S. C., Lewine R. J., Kalin N. H., Jewart R. D., Risby E. D., Caudle J. M., Stipetic M., Turner J., Eccard M. B., Pollard W. E. Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia. Neuropsychopharmacology. 6(2):1992;95-100.
117. Ritchie J. C., Nemeroff C. B. The extracellular metabolism of corticotropin-releasing factor: A potential new target for neuropsychiatric interventions. Biol. Psychiatry. 42:1997;272S.
118. Romero L. M., Sapolsky R. M. Patterns of ACTH secretagog secretion in response to psychological stimuli. J. Neuroendocrinology. 8:1996;243-258.
119. Rose, R. M., Overview of endocrinology of stress. In Neuroendocrinology and Psychiatric Disorders, ed. G. M. Brown and S. H. Koslow. Raven Press, New York, 1984, pp. 95-122.
120. Roy A., Pickar D., Paul S., Doran A., Chrousos G. P., Gold P. W. CSF corticotropin-releasing hormone in depressed patients and normal control subjects. Am. J. Psychiatry. 144:1987;641-645.
121. Roy A. Neuropeptides in relation to suicidal behaviour in depression. Neuropsychobiology. 28:1993;184-186.
122. Rubin R. T., Phillips J. J., Sadow T. F., McCracken J. T. Adrenal gland volume in major depression increase during depressive episode and decrease with successful treatment. Arch. Gen. Psychiatry. 52:1995;213-218.
123. Rudorfer M. V., Risby E. D., Osman O. T., Gold P. W., Potter W. Z. H-P-A axis and monoamine transmitter activity in depression: A pilot study of central and peripheral effects of ECT. Biol. Psychiatry. 29:1991;253-264.
124. Sapolsky R. M. Do glucocorticoid concentrations rise with age in the rat? Neurobiol. Aging. 13:1991;171-174.
125. Sapolsky, R. M., The physiological relevance of glucocorticoid endangerment of the hippocampus. In Brain Corticosteroid Receptors Studies on the Mechanism, Function, and Neurotoxicity of Corticosteroid Action, Vol. 746, ed. E. R. De Kloet, E. C. Azmitia and P. W. Landfield. Ann. N. Y. Acad. Sci., 1994, pp. 294-307.
126. Schulte H., Chrousos G., Gold P., Booth J., Oldfield T., Cutler G. Jr., Loriaux D. Continuous infusion of CRF in normal volunteers: Physiological and pathophysiological implications. J. Clin. Invest. 75:1985;1781-1785.
127. Seckl J. R., Olsson T. Glucocorticoid hypersecretion and the age-impaired hippocampus: Cause or effect? J. Endocrinology. 145:1995;201-211.
128. Seemnan T. E., Singer B., Charpentier P. Gender differences in patterns of HPA axis response to challenge: MacArthur studies of successful aging. Psychoneuroendocrinology. 20(7):1995;711-725.
129. Seeman T. E., Robbins R. J. Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr. Rev. 15(2):1994;233-260.
130. Sharma R. P., Pandey G. N., Janicak P. G., Peterson J., Comaty J. E., Davis J. M. The effect of diagnosis and age on the DST: A metaanalytic approach. Biol. Psychiatry. 24:1988;555-568.
131. Skutella T., Montkowski A., Stöhr T., Probst J. C., Landgraf R., Holsboer F., Jirikowski G. F. Corticotropin-releasing hormone oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats. Cell. Molec. Neurobiol. 14(5):1994;579-588.
132. Smith M. A., Bissette G., Slotkin T. A., Knight D. L., Nemeroff C. B. Release of corticotropin-releasing factor from rat brain regions in vitro. Endocrinology. 118:1986;1997-2001.
133. Smith M. A., Kling M. A., Whitfield H. J., Brandt H. A., Demitrack M. A., Geracioti T. D., Chrousos G. P., Gold P. W. Corticotropin-releasing hormone from endocrinology to psychobiology. Horm. Res. 31:1989;66-71.
134. Spitzer, R. L. and Endicott, J., Schedule for Affective Disorders and Schizophrenia - Lifetime Version. Biometric Research, New York State Psychiatric Institute, 1978.
135. Spitzer, R. L., Endicott, J. and Robins, E., Research Diagnostic Criteria, 3rd edn. Biometric Research, New York State Department of Health, 1977.
136. Strijbos P. J., Relton J. K., Rothwell N. J. Corticotropin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischemia or activation of NMDA receptors in the rat brain. Brain Res. 656(2):1994;405-408.
137. Stokes, P. E., The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. European Neuropsychopharm. Supp., 1995, 77-82.
138. Suda T., Tozawa F., Mouri T., Demura H., Shizume K. Presence of immunoreactive corticotropin-releasing factor in human cerebrospinal fluid. J. Clin. Endocrin. Metab. 57(1):1983;225-226.
139. Szigethy E., Conwell Y., Forbes N. T., Cox C., Caine E. D. Adrenal weight and morphology in victims of completed suicide. Biol. Psychiatry. 36:1994;374-380.
140. Thakore J. H., Dinan T. G. Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression. Biol. Psychiatry. 37:1995;364-368.
141. Thoman E. B., Levine S., Arnold W. J. Effects of maternal deprivation and incubator rearing on adrenocortical activity in the adult rat. Develop. Psychobiol. 1(1):1968;21-23.
142. Ur E. Psychological aspects of HPA activity. Bailliere's Clinical Endoc. and Met. 5(1):1991;79-96.
143. Ur E., Dinan T. G., O'Keane V., Clare A. W., McLoughlin L., Rees A. H., Turner T. H., Grossman A., Besser M. Effect of metyrapone on the pituitary-adrenal axis in depression: Relation to dexamethasone suppressor status. Neuroendocrinology. 56:1992;533-538.
144. Ur E., Capstick C., Checkley S., Besser M., Grossman A. Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man. Neuroendocrinology. 61:1995;191-197.
145. Vale W. J., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-Endorphin. Science. 213:1981;1394-1396.
146. Veith R. C., Lewis N., Langohr J. I., Murburg M. M., Ashleigh E. A., Castillo S., Peskind E. R., Pascualy M., Bissette G., Nemeroff C. B., Raskind M. A. Effect of desipramine on cerebrospinal concentrations of corticotropin-releasing factor in human subjects. Psych. Res. 46:1993;1-8.
147. Von Bardeleben U., Stalla G. K., Mueller O. A., Holsboer F. Blunting of ACTH response to CRH in depressed patients is avoided by metyrapone pretreatment. Biol. Psychiatry. 24:1988;782-786.
148. Von Bardeleben U., Holsboer F. Cortisol response to a combined dexamethasone hCRH challenge in patients with depression. J. Neuroendocrinology. 1:1989;485-488.
149. Westrin Å., Ekman R., Regnéll G., Träskman-Bendz L. Is suicidality correlated with hypothalamo-pituitary adrenocortical (HPA)-system related peptides? (abstract). Biol. Psychiatry. 42:1997;48S.
150. Widerlöv, E., Wahlestedt, C., Håkanson, R. and Ekman, R., Altered brain neuropeptide function in psychiatric illnesses - with special emphasis on NPY and CRF in major depression. Abstr 15th Int. Neuropsychopharmacology s-239, 1986, Vol. 9(4) pp. 572-574.
151. Widerlöv E., Bissette G., Nemeroff C. B. Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients. J. Aff. Dis. 14:1988;99-107.
152. Widerlöv E., Ekman R., Jensen L., Borglund L., Nyman K. Argenine vasopressin, but not corticotropin releasing factor is a potent stimulator of adrenocorticotropin hormone following electroconvulsive treatment. J. Neural. Transm. 75:1989;101-109.
153. Wynn P. C., Harwood J. P., Catt K. J., Aguilera G. Regulation of corticotropin-releasing factor receptors in the rat pituitary gland Effects of adrenalectomy of CRF receptors and corticotroph responses. Endocrinology. 166:1985;1653-1659.
154. Young E. A., Lopez J. F., Murphy-Weinberg V., Watson S. J., Akil H. Normal pituitary response to metyrapone in the morning in depressed patients: Implications for circadian regulation of corticotropin-releasing hormone secretion. Biol. Psychiatry. 41:1997;1149-1155.
155. Zhou Y., Spangler R., LaForge K. S., Maggos C. E., Ho A., Kreek M. J. Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: Correlation with POMC mRNA. Peptides. 17(3):1996;435-441.